by EmpathiCSubstanceS | Nov 10, 2020 | Pain
In a first-of-its-kind study, a team of researchers from the University of California, Davis has examined the effects of psychedelic microdosing on animal behavior. The results yielded a variety of unexpected effects including some surprising negative changes...
by EmpathiCSubstanceS | Nov 10, 2020 | Pain
New research suggests the potential for psychedelic drugs to stimulate new neuron production may be able to be separated from the drugs’ hallucinogenic effects. Robust new research, published in the journal Translational Psychiatry, is reporting on several years...
by EmpathiCSubstanceS | Nov 10, 2020 | Addiction, Alcoholism, Anxiety, Bipolar Disorder, Cancer, Cluster Headaches, Depression, Kambo, Microdosing, Neuropathy, OCD, Pain, Parkinson's Disease, PTSD
Psychedelics Renaissance As psychedelic research re-emerges from its dark ages, the world is beginning to learn about their healing potential for various psychological disorders such as post-traumatic stress disorder, depression, and near-death anxiety due to terminal...
by EmpathiCSubstanceS | Nov 6, 2020 | Pain
The compound, called 2 C-H, reduces inflammation without mind-altering effects People have long believed that using psychedelic drugs such as LSD, DMT, and psilocybin (from ″magic mushrooms”) can help the body fight inflammation. Scientific support for this idea...
by EmpathiCSubstanceS | Jul 13, 2020 | Pain
Using psychedelics to treat chronic pain is understudied yet full of potential. In a May 2020 paper published in the journal Regional Anesthesia and Pain Medicine, researchers from the University of California San Diego reviewed the psychedelic literature and proposed...
by EmpathiCSubstanceS | Feb 8, 2020 | Cancer, Pain, PTSD
A team of researchers from King’s College London has, for the first time, imaged the brains of patients with psychosis under the influence of cannabidiol (CBD). The study demonstrates the anti-psychotic potential of CBD, suggesting large clinical trials are necessary....
